NEW YORK, April 18, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Platform Specialty Products Corporation (“Platform”) (NYSE:PAH) between February 17, 2015 and March 14, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired Platform securities between February 17, 2015 and March 14, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/platform-specialty-products-corporation.
On February 17, 2015, Platform completed its acquisition of Arysta LifeScience Limited. The complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Arysta made improper third-party payments in West Africa; (2) such payments were unlawful under the U.S. Foreign Corrupt Practices Act; and (3) as a result, Platforms’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in Platform you have until June 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/platform-specialty-products-corporation.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 



